Several samples had missing or ambiguous status for the two main prognostic and treatment‐predictive biomarkers in breast cancer: oestrogen receptor alpha (ER, gene symbol ESR1) and Erb‐B2 receptor tyrosine kinase 2 (HER2, gene symbol ERBB2). Here, ESR1 is linked to breast carcinoma.